AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
There are two paths of the adaptive immune response: the humoral response that uses antibodies, and the cell-mediated response which uses cytotoxic T cells. Antibodies are small Y shaped proteins that ...
These anti-immune complex antibodies have not been studied in very much depth, especially in the context of HIV vaccination. Understanding these responses could lead to smarter vaccine designs and ...
Median 4-week preF IgG fold rise was 4.21; 61% of participants achieved seroconversion. (HealthDay News) — For immunocompromised individuals, antibody response to respiratory syncytial virus ...
Antibody-mediated immunity is crucial for preventing and limiting viral infections, and potent neutralizing antibodies could serve as potential therapeutic agents. In this review, we describe recent ...